-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Kiora Pharmaceuticals Inc quarterly/annual Revenues history and growth rate from Q2 2017 to Q3 2024.
- Kiora Pharmaceuticals Inc Revenues for the quarter ending September 30, 2024 was $0.000.
- Kiora Pharmaceuticals Inc annual Revenues for 2018 was $1.65M, a 306% increase from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)